Miguel-Angel Perales, MD

Miguel-Angel Perales, MD, is an internationally recognized leader in stem cell transplantation and cellular therapy. He is Co-Chair of the CAR T Vision Steering Committee, Past-President of American Society for Transplantation and Cellular Therapy (ASTCT), Chief of the Adult Bone Marrow Transplantation Service at Memorial Sloan Kettering Cancer Center (MSK), and Professor of Medicine at Weill Cornell Medical College. Dr. Perales has more than 450 publications, has held leadership roles in multiple hematological organizations, and trained at the Free University of Brussels, Tufts Medical Center, Harvard Medical School, and MSK. Perales reports honoraria from Allogene, Celgene, Bristol-Myers Squibb, Exevir, ImmPACT Bio, Incyte, Kite/Gilead, Merck, Miltenyi Biotec, Nektar Therapeutics, Novartis, Omeros, OrcaBio, Pierre Fabre, Sanofi, Syncopation, Takeda, VectivBio AG, and Vor Biopharma. He serves on DSMBs for Cidara Therapeutics and Sellas Life Sciences. He has ownership interests in Omeros and OrcaBio. He has received institutional research support for clinical trials from Allogene, Genmab, Incyte, Kite/Gilead, Miltenyi Biotec, Novartis, and Tr1x.